IHS Chemical Week

Regions :: Western Europe :: Sweden

Roche Sells Four Products to Swedish Firm for €120 million

2:25 AM MDT | August 15, 2008 | Deepti Ramesh

Roche says it has signed an agreement to sell four of its pharmaceutical products to specialty pharmaceutical company Meda (Solna, Sweden). The worldwide product rights are being sold for a total of €120 million, and the transaction is expected to close by the end of the year, Roche says. The acquired products, which include an anticoagulant, a loop diuretic, a drug for the treatment of painful inflammatory and degenerative disorders, and an antidepressant, have strong brand names and a total sales of about SEK 500 million ($80 million), Meda says. The most...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa